Want to see IN:DRREDDY full AI Analyst Report?
Total Valuation
Dr. Reddy's Laboratories Ltd. has a market cap or net worth of ₹957.40B. The enterprise value is ₹1.12M.
Market Cap₹957.40B
Enterprise Value₹1.12M
Share Statistics
Dr. Reddy's Laboratories Ltd. has 834,636,800 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding834,636,800
Owned by Insiders―
Owned by Institutions―
Financial Efficiency
Dr. Reddy's Laboratories Ltd.’s return on equity (ROE) is 0.11 and return on invested capital (ROIC) is 7.54%.
Return on Equity (ROE)0.11
Return on Assets (ROA)0.07
Return on Invested Capital (ROIC)7.54%
Return on Capital Employed (ROCE)0.11
Revenue Per Employee12.20M
Profits Per Employee1.54M
Employee Count27,527
Asset Turnover0.58
Inventory Turnover2.07
Valuation Ratios
The current PE Ratio of Dr. Reddy's Laboratories Ltd. is 28.9. Dr. Reddy's Laboratories Ltd.’s PEG ratio is -1.01.
PE Ratio28.9
PS Ratio3.11
PB Ratio2.77
Price to Fair Value2.77
Price to FCF34.24
Price to Operating Cash Flow23.97
PEG Ratio-1.01
Income Statement
In the last 12 months, Dr. Reddy's Laboratories Ltd. had revenue of 335.93B and earned 42.85B in profits. Earnings per share was 51.48.
Revenue335.93B
Gross Profit177.26B
Operating Income46.44B
Pretax Income54.82B
Net Income42.85B
EBITDA79.16B
Earnings Per Share (EPS)51.48
Cash Flow
In the last 12 months, operating cash flow was 39.78B and capital expenditures -25.08B, giving a free cash flow of 14.71B billion.
Operating Cash Flow39.78B
Free Cash Flow14.71B
Free Cash Flow per Share17.62
Dividends & Yields
Dr. Reddy's Laboratories Ltd. pays an annual dividend of ₹8, resulting in a dividend yield of 0.7%
Dividend Per Share₹8
Dividend Yield0.7%
Payout Ratio20.13%
Free Cash Flow Yield―
Earnings Yield―
Stock Price Statistics
Beta0.44
52-Week Price Change-5.76%
50-Day Moving Average1.26K
200-Day Moving Average1.25K
Relative Strength Index (RSI)26.24
Average Volume (3m)225.11K
Important Dates
Dr. Reddy's Laboratories Ltd. upcoming earnings date is Oct 23, 2026, Before Open (Confirmed).
Last Earnings DateJul 22, 2026
Next Earnings DateOct 23, 2026
Ex-Dividend Date―
Financial Position
Dr. Reddy's Laboratories Ltd. as a current ratio of 1.80, with Debt / Equity ratio of 18.77%
Current Ratio1.80
Quick Ratio1.35
Debt to Market Cap0.07
Net Debt to EBITDA0.94
Interest Coverage Ratio12.42
Taxes
In the past 12 months, Dr. Reddy's Laboratories Ltd. has paid 12.35B in taxes.
Income Tax12.35B
Effective Tax Rate0.23
Enterprise Valuation
Dr. Reddy's Laboratories Ltd. EV to EBITDA ratio is 14.13, with an EV/FCF ratio of 36.67.
EV to Sales3.33
EV to EBITDA14.13
EV to Free Cash Flow36.67
EV to Operating Cash Flow20.78
Balance Sheet
Dr. Reddy's Laboratories Ltd. has ₹81.43B in cash and marketable securities with ₹71.95B in debt, giving a net cash position of ₹9.47B billion.
Cash & Marketable Securities₹81.43B
Total Debt₹71.95B
Net Cash₹9.47B
Net Cash Per Share₹11.35
Tangible Book Value Per Share₹315.37
Margins
Gross margin is 50.18%, with operating margin of 13.83%, and net profit margin of 12.76%.
Gross Margin50.18%
Operating Margin13.83%
Pretax Margin16.32%
Net Profit Margin12.76%
EBITDA Margin23.56%
EBIT Margin17.43%
Analyst Forecast
The average price target for Dr. Reddy's Laboratories Ltd. is ―, which is 11.43% higher than the current price. The consensus rating is ―
Price Target―
Price Target Upside―
Analyst Consensus―
Analyst Count0
Revenue Growth Forecast-0.92%
EPS Growth Forecast-41.73%